Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enable... Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates. Show more
BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines...
MRT-6160, a potent and highly selective VAV1-directed molecular glue degrader, represents a potential novel therapeutic approach for systemic and neurological autoimmune and inflammatory diseases...
IND clearance achieved for MRT-6160, a VAV1-directed MGD in development for systemic and neurological autoimmune diseases; on track to initiate Phase 1 SAD/MAD study this summer with initial...
BOSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines...
Ongoing Phase 1/2 Study of MRT-2359 for MYC-driven solid tumors demonstrates favorable safety and pharmacodynamic profile dosing 0.5 mg using a 21/7 schedule; currently assessing 0.75 mg dose...
MRT-6160, a VAV1-directed molecular glue degrader (MGD), inhibits disease progression, pro-inflammatory cytokines and autoantibody production in a model of rheumatoid arthritis Initiation of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.105 | -1.73985086993 | 6.035 | 6.25 | 5.44 | 161983 | 5.78079939 | CS |
4 | 1.95 | 48.9949748744 | 3.98 | 7.08 | 3.7411 | 218385 | 5.88465039 | CS |
12 | 2.17 | 57.7127659574 | 3.76 | 7.08 | 3.21 | 234057 | 4.5922022 | CS |
26 | -0.44 | -6.90737833595 | 6.37 | 8.84 | 3.21 | 207522 | 5.02216178 | CS |
52 | -0.07 | -1.16666666667 | 6 | 8.84 | 2.44 | 219173 | 4.77214545 | CS |
156 | -29.47 | -83.2485875706 | 35.4 | 36.64 | 2.44 | 205028 | 8.99436761 | CS |
260 | -16.07 | -73.0454545455 | 22 | 45.56 | 2.44 | 210124 | 10.49450498 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.